Jim Simons
ORIC icon

Jim Simons’s Oric Pharmaceuticals ORIC Stock Holding History

Jim Simons’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-572,724
Closed -$4.68M – 3569
2025
Q4 		$4.68M Buy
572,724
+558,224
+3,850% +$6.43M 0.01% 1342
2025
Q3 		$174K Buy
14,500
+4,300
+42% +$45.2K ﹤0.01% 3155
2025
Q2 		$104K Buy
+10,200
New +$68.5K ﹤0.01% 3294
2024
Q4 		– Sell
-13,700
Closed -$140K – 3813
2024
Q3 		$140K Sell
13,700
-33,300
-71% -$329K ﹤0.01% 3197
2024
Q2 		$332K Sell
47,000
-63,900
-58% -$572K ﹤0.01% 2868
2024
Q1 		$1.52M Sell
110,900
-77,600
-41% -$922K ﹤0.01% 2211
2023
Q4 		$1.73M Sell
188,500
-191,300
-50% -$1.38M ﹤0.01% 2044
2023
Q3 		$2.3M Buy
379,800
+36,100
+11% +$296K ﹤0.01% 1774
2023
Q2 		$2.67M Sell
343,700
-400
-0.1% -$2.27K ﹤0.01% 1818
2023
Q1 		$1.96M Buy
344,100
+27,300
+9% +$143K ﹤0.01% 2040
2022
Q4 		$1.87M Sell
316,800
-84,600
-21% -$286K ﹤0.01% 2113
2022
Q3 		$1.28M Sell
401,400
-46,469
-10% -$186K ﹤0.01% 2345
2022
Q2 		$2.01M Buy
447,869
+228,769
+104% +$913K ﹤0.01% 2193
2022
Q1 		$1.17M Buy
219,100
+192,800
+733% +$1.74M ﹤0.01% 2629
2021
Q4 		$387K Buy
+26,300
New +$410K ﹤0.01% 3209

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Jim Simons's ORIC Position: Q1 2026 in Review

Jim Simons sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 572,724 shares — an estimated $4.68M sold.

Jim Simons first reported a position in ORIC in Q4 2021 and held it in 15 quarters. The position peaked at $4.68M in Q4 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Jim Simons reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 572,724 Oric Pharmaceuticals shares in Q1 2026, an estimated $4.68M.
  • Jim Simons first reported a position in Oric Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Jim Simons's Oric Pharmaceuticals position peaked at $4.68M in Q4 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.